References
- Atar A, Gedikbasi A, Sonmezay E, et al. Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis. Ren Fail. 2016;38:378–382.
- Tsao KC, Wu TL, Chang PY, Sun CF, Wu LL, Wu JT. Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal. 2007;21:426–431.
- West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: The National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis. 2008;51:741–747.
- Kim YJ, Kim CH, Sung EJ, Kim SR, Shin HC, Jung WJ. Association of nephrolithiasis with metabolic syndrome and its components. Metab Clin Exp. 2013;62:808–813.
- Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–915.
- Pak CY, Sakhaee K, Moe O, et al. Biochemical profile of stone forming patients with diabetes mellitus. Urology. 2003;61:523–527.